8-K: Current report filing
Published on February 26, 2009
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): February 20,
2009
|
CryoPort,
Inc.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Nevada
|
000-51578
|
88-0313393
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
20382
Barents Sea Circle, Lake Forest, California
|
92630
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (949)
470-2300
|
Not
Applicable
|
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 1 4a- 12 under the Exchange Act (17 CFR
240.1 4a- 12)
[ ]
Pre-commencement communications pursuant to Rule 1 4d-2(b) under the Exchange
Act (17 CFR 240.1 4d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 1 3e-4(c) under the Exchange
Act (17 CFR 240.1 3e-4(c))
Item
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory
Arrangements of Certain
Officers.
On
February 20, 2009 the Company’s Board of Directors elected Larry G. Stambaugh to
fill the positions of President and Chief Executive Officer of the Company as
well as to maintain his position on the Board as Chairman. Mr. Stambaugh's
election was effective immediately. The compensation package is currently under
review by the Company’s Compensation and Governance Committee and will be filed
for public view as soon as it is finalized.
Mr.
Stambaugh, besides serving as the Company’s Chairman, is currently a Principal
of Apercu Consulting where he serves as an advisor to several private and public
boards and CEOs, concentrating on strategic business direction, turnarounds and
board governance. Mr. Stambaugh brings to the Company more than 30
years of successful experience building public and private global businesses and
setting strategies. He also brings an extensive background in life sciences and
clean tech including relationships with and knowledge of Contract Research
Organizations (CRO’s), biotech and pharmaceutical companies.
Peter
Berry, the prior President and Chief Executive Officer, has taken on an advisory
role with the Company as a consultant to Mr. Stambaugh, and will retain his seat
on the Board of Directors.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
CryoPort,
Inc.
|
|
|
(Registrant)
|
|
|
Date:
February 26, 2009
|
By:
/s/ Larry
Stambaugh
|
|
Larry
Stambaugh
|
|
|
Chief
Executive Officer, President
|